Imexpharm

Imexpharm Tax Expense

The Income Tax Expense of Imexpharm (IMP.VN) as of Oct 26, 2026 is 97.11 B VND. In the previous year, Income Tax Expense was 83.33 B VND — a change of 16.54% (higher).

Tax Expense

97.11 BVND

YoY

16.54%

Last updated:

Income Tax Expense of Imexpharm is 2025 97.11 B VND. Income Tax Expense of Imexpharm was 2024 83.33 B VND. It decreases by 16.54% higher compared to the previous year.

The Imexpharm Tax Expense history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Tax Expense
Date
Tax Expense
Jan 1, 2018
35.09 B VND
Jan 1, 2019
40.04 B VND
Jan 1, 2020
45.74 B VND
Jan 1, 2021
49.76 B VND
Jan 1, 2022
67.86 B VND
Jan 1, 2023
77.72 B VND
Jan 1, 2024
83.33 B VND
Jan 1, 2025
97.11 B VND
The Imexpharm Tax Expense history
YEARTax ExpenseYoY
97.11 BVND+16.54%
83.33 BVND+7.22%
77.72 BVND+14.52%
67.86 BVND+36.37%
49.76 BVND+8.79%
45.74 BVND+14.24%
40.04 BVND+14.13%
35.09 BVND+20.16%
29.20 BVND+15.15%
25.36 BVND-1.60%
25.77 BVND+5.17%
24.50 BVND—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Imexpharm Stock analysis

What does Imexpharm do? Imexpharm Corp manufactures and trades pharmaceuticals, medicinal chemicals, and botanical products, including antiseptics, traditional medicine, medical equipment, cosmetics, and supplemental food and drinks. The company provides packaging and warehousing services specifically for pharmaceutical storage. It also cultivates medicinal herbs. Imexpharm Corp serves the pharmaceutical industry and healthcare sector through its manufacturing, import, export, and trade operations, targeting businesses requiring medicinal products and services. The company's revenue streams include the sale of manufactured pharmaceuticals, imported and exported goods, and services such as packaging and warehousing. Its customers are businesses in the healthcare sector, including distributors and retailers of pharmaceuticals, medical equipment, and related products. The firm's operations span manufacturing, import, export, and trade, with additional services supporting the pharmaceutical supply chain. Imexpharm Corp's product portfolio covers a wide range of medicinal and health-related items, from antiseptics to supplemental food and drinks. The company's involvement in medicinal herb cultivation supports its production of traditional medicine and herbal-based products. This vertical integration enhances its ability to supply comprehensive solutions to healthcare businesses. Imexpharm is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Imexpharm stock

Income Tax Expense of Imexpharm is 97.11 B VND in 2025.

Income Tax Expense of Imexpharm changed from 83.33 B VND to 97.11 B VND, representing a 16.54% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Income Tax Expense Imexpharm since 2006 – with annual values, charts, and detailed analysis.

Tax expense represents the total income taxes owed. It reflects the company's tax obligations and effective tax rate.

Income Tax Expense's VND is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Income Tax Expense's Imexpharm historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Imexpharm

All Key Metrics — Imexpharm